Health and science news from Florida. Personal account, views my own.

Boynton Beach, FL
Joined April 2009
Stacey S DeLoye retweeted
1) 🔬 New funding opportunity for ME/CFS research! Solve is now accepting submissions for their Ramsay Research Grant Program! Funding is between $50.000 - $150.000 depending on the category. The deadline to apply is Friday, November 13, 2026.
3
21
1
43
1,394
Stacey S DeLoye retweeted
The US government will give your startup up to $1.55M and take 0% equity. @NSF's America's Seed Fund is open again after Congress reauthorized it in April. Three tracks: - Phase I: up to $305K to prove the idea - Phase II: up to $1.25M to build it - Fast-Track: up to $1.55M, both phases in one go Who can apply: - US-based startups with 500 or fewer employees - 51%+ owned by US citizens or permanent residents - Not majority owned by VCs - All the work done in the US How it works: - Send a 3-page Project Pitch first - NSF invites the best ones to submit a full proposal - Next full proposal deadline: Nov 4 Phase I funding rates have run about 10 to 20%. It's work, but nobody takes your cap table. Application link 👉 seedfund.nsf.gov Bookmark and tag a tech founder who needs this.
171
508
93
5,446
637,449
Stacey S DeLoye retweeted
New from France 🇫🇷 Interesting long Covid research where all participants satisfy ME/CFS criteria Evidence for transcriptomic changes impacting muscle contraction in patients with post-acute COVID-19 syndrome sciencedirect.com/science/ar… #LongCovid #MEcfs
2
24
1
75
2,403
Stacey S DeLoye retweeted
Sharing for those here in the Bay: @ChronicleBioAI is looking for ME/CFS patients to enroll in their biobank study who are able to give a blood sample at their Menlo Park lab. They are currently looking at specific biomarkers and immune cells. connect.chroniclebio.com/sig… – at Menlo Park, CA
2
22
1
39
6,154
I’m thinking of all the young ones who develop severe ME/CFS from long covid. Science can solve this.
I so love this kid. For as horrifically limited as his daily life is, he has a remarkably good attitude and makes the most of the windows where he has the energy and clarity of mind he so desperately wants more of. Bless him and the others suffering with #longcovid or #mecfs
7
311
This message is for everyone and anyone who turns 18 before Oct. 5. Please share it with everyone you know who is turning 18. October 5 is a very important date in #FL, because it is the deadline to register to vote in the Nov. 3 elections. 1/2
1
1
1
206
Now you may think, “I don’t know who any of these candidates are, so I’m not going to bother.” There’s an easy for fix that. At vote411.org/ you can plug in your address and see what’s on your ballot along with Q&A’s with candidate for office, in their own words.
68
Just watched the first episode of the second season of #TedLasso. Wow, what hot garbage. Does it improve? I really enjoyed the first season. What gives?
3
1
783
ARDS, acute respiratory distress syndrome, strikes 2M worldwide, with 40% mortality. A new therapy shows promise. wertheim.scripps.ufl.edu/202… @WertheimUFScrip #ARDS #ARDSAwareness #clinicaltrials @UFHealth @UF_Research
1
1
1
153
Stacey S DeLoye retweeted
The most promising longevity drug isn't a peptide or metformin. It's the Shingles vaccine. New data shows it slows biological aging and lowers systemic inflammation for 4+ years post-shot. We are seeing a 20% reduction in new dementia diagnoses and a 25% lower risk of stroke. Stop waiting for a magic pill. One is already on the shelf. – at New York, USA
🤖 Made with AI
218
900
73
4,076
307,332
Stacey S DeLoye retweeted
Long term follow up of a phase 1 trial of an mRNA tumor vaccine shows that 7/8 patients with pancreatic cancer, who mounted an immune response to the vaccine, are still alive 6 years later. This is breathtaking data and shows the promise of mRNA vaccines. nbcnews.com/health/cancer/pa…
163
2,406
172
9,110
680,892
Stacey S DeLoye retweeted
The independent research by a world renowned breast cancer oncologist at UCLA, Dr Aditya Barda, breaks news today at AACR that consistently shows regardless of the stage of BREAST CANCER, that post Covid lymphopenia results in poorer prognosis, poorer response to treatment and even 2x higher recurrence when patients are in remission. The relationship of low NK and low T cells to breast cancer ( and frankly all cancers ) is so clear. Will share his data that he presented at major breast cancer conferences and now at AACR next. Very compelling
38
517
45
2,142
166,210
Stacey S DeLoye retweeted
Study of neuro #LongCovid patients found pTau-181 (marker of Alzheimer's/brain injury) increased by 59% after COVID. Interestingly, levels increased more AFTER 1.5 years from infection (only 15% increased in the before-1.5 year time period). thelancet.com/journals/ebiom… 1/
3
478
47
1,158
75,687
“An analysis by the Florida Policy Institute found that Florida would have to double its sales tax to 12% to replace lost property tax revenue. The move would make the state sales tax the nation's highest.” yahoo.com/news/articles/desa…
156
251
54
457
130,310
Stacey S DeLoye retweeted
Here is our updated database of grants for early careers researchers in all fields. It goes way beyond traditional NIH and NSF funding opportunities. We list 428 types of grants. Download it here: research.jhu.edu/rdt/funding…
13
372
8
1,196
153,145
Stacey S DeLoye retweeted
A recent study in Nature Communications reveals over 250 metabolic enzymes located directly on chromatin, a discovery that vastly expands the previously known count of only about 20. nature.com/articles/s41467-0…
4
108
3
337
23,992
Think about what this means for health care. Insurance authorizations. EMRs.
This is the most important signal in AI right now, and most people are reading it wrong. The story isn't "AI broke Amazon." The story is that the largest cloud infrastructure company on Earth, spending $200 billion on AI this year, still hasn't solved the governance layer between AI-generated code and production systems. The timeline tells you everything: → Amazon mandated 80% weekly AI coding tool adoption → Their own Kiro agent was given operator-level permissions with no peer review → It autonomously deleted and rebuilt a live AWS environment. 13 hours of downtime. → A second AI tool incident followed months later → Last Thursday, the retail site went down for 6 hours. 21,000+ users locked out of checkout. → Today, a mandatory all-hands to address "a trend of incidents" they can no longer downplay Amazon's fix: junior and mid-level engineers can no longer push AI-assisted code without senior approval. They're calling it "controlled friction." That phrase alone should be on every engineering team's wall. The companies winning with AI coding tools aren't the ones moving fastest. They're the ones who built review gates, permission boundaries, and deterministic checks before handing agents the keys to production. Speed without governance isn't velocity. It's liability. Every team deploying AI in their dev workflow should be asking three questions right now: What permissions does our AI tooling actually have? Is there a mandatory human checkpoint before any destructive operation? Are we tracking AI-assisted changes separately in our deployment pipeline? Amazon learned this in production. You don't have to.
204
Now do K cups.
Chewing gum releases thousands of microplastic particles directly into your mouth with every piece you chew. A pilot study from UCLA researchers, presented at the American Chemical Society’s Spring 2025 meeting, has identified chewing gum as a surprisingly significant and previously overlooked source of daily microplastic ingestion. The researchers examined both traditional synthetic gums, which contain polymers such as polyethylene, polyvinyl acetate, and polystyrene, as well as brands marketed as “natural” that use chicle or other plant-based bases. By simulating realistic chewing conditions, they measured how many particles are released into saliva during typical use. The results showed that a single piece of gum can shed anywhere from hundreds to more than 3,000 microplastic fragments over 10 to 30 minutes of chewing. The primary mechanism is mechanical abrasion from teeth combined with friction from saliva, which dislodges tiny particles directly from the gum base. Surprisingly, “natural” gums performed no better than synthetic versions and, in some cases, released even higher numbers of fragments. Most of the particles fell within the microplastic size range of less than 5 millimeters, making them small enough to be easily swallowed. Once ingested, these particles largely resist breakdown by digestive enzymes and pass through the gastrointestinal tract as persistent pollutants. Although the long-term health consequences of chronic low-level microplastic exposure are still under investigation—with emerging concerns about potential links to inflammation, gut microbiome changes, and leaching of chemicals—this represents a meaningful everyday contribution to personal plastic intake, especially for regular gum chewers. Lead researcher Professor Sanjay Mohanty pointed out a practical way to reduce exposure: chewing a single piece for a longer time rather than frequently replacing it with a fresh one, since particle release tends to be highest in the early minutes and then decreases. The study underscores the need for greater transparency in labeling the materials used in everyday consumer products like chewing gum. As microplastics continue to appear in unexpected places—from drinking water to seafood—this discovery adds chewing gum to the expanding list of common items quietly adding to our daily plastic burden. [Lowe, L., Leonard, J., & Mohanty, S. K. (2025). Ingestion of microplastics during chewing gum consumption. Journal of Hazardous Materials Letters, 6, 100164. DOI: 10.1016/j.hazl.2025.100164]
134